Chronic Obstructive Pulmonary Disease

Showing NaN - NaN of 44

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COPD Trial in Worldwide (Benralizumab, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Benralizumab
  • Placebo
  • Montgomery, Alabama
  • +400 more
Jan 11, 2023

COPD Trial in Worldwide (Itepekimab SAR440340, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Itepekimab SAR440340
  • Placebo
  • Palm Springs, California
  • +231 more
Dec 19, 2022

COPD Trial in Worldwide (Ensifentrine, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Alabaster, Alabama
  • +140 more
Nov 30, 2022

COPD Trial in Worldwide (Astegolimab, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Andalusia, Alabama
  • +170 more
Aug 4, 2022

COPD Trial in Worldwide (Dupilumab SAR231893, Inhaled Corticosteroid, Inhaled Long-Acting Beta Agonist)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Dupilumab SAR231893
  • +4 more
  • Cullman, Alabama
  • +334 more
Jun 14, 2022

COPD, COPD Trial in United States (CHF 5259, Placebo, Tiotropium Bromide 18 µg Inhalation Capsule)

Completed
  • COPD
  • Chronic Obstructive Pulmonary Disease
  • CHF 5259
  • +2 more
  • Birmingham, Alabama
  • +111 more
May 20, 2021

COPD Trial in San Diego (Portable Oxygen Cylinder, Mobi)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Portable Oxygen Cylinder
  • Mobi
  • San Diego, California
    SleepData
May 24, 2021

Copd, COPD, Hypercapnia Trial in San Diego (High-intensity non-invasive ventilation)

Terminated
  • Copd
  • +4 more
  • High-intensity non-invasive ventilation
  • San Diego, California
    University of California San Diego
Aug 24, 2020

Obstructive Sleep Apnea, COPD, Overlap Syndrome Trial in San Diego (Bi-level positive airway pressure (BPAP), Nocturnal oxygen)

Completed
  • Obstructive Sleep Apnea
  • +2 more
  • Bi-level positive airway pressure (BPAP)
  • Nocturnal oxygen
  • San Diego, California
    University of California, San Diego
Jul 13, 2020

COPD, COPD, Moderate to Very Severe COPD Trial in Canada, United States (Aclidinium Bromide, Placebo)

Completed
  • COPD
  • +2 more
  • Aclidinium Bromide
  • Placebo
  • Birmingham, Alabama
  • +467 more
Nov 8, 2018

COPD Trial in Worldwide (Aclidinium bromide 400 µg/Formoterol Fumarate 12 µg (AB/FF 400/12 µg), Aclidinium bromide 400 µg (AB

Completed
  • Chronic Obstructive Pulmonary Disease
  • Aclidinium bromide 400 μg/Formoterol Fumarate 12 μg (AB/FF 400/12 μg)
  • +5 more
  • Gulf Shores, Alabama
  • +162 more
Nov 7, 2018

Data of Adipose Stem Cells to Treat Chronic Obstructive

Unknown status
  • Chronic Obstructive Pulmonary Disease
    • San Diego, California
      StemGenex
    Aug 28, 2018

    COPD Trial in United States (QVA149, Umeclidinium/vilanterol, Placebo (umeclidinium/vilanterol ))

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Anaheim, California
    • +52 more
    Mar 2, 2018

    COPD, COPD Trial in United States (SUN-101 50 mcg BID eFlow (CS) nebulizer, SUN-101 25 mcg BID eFlow (CS) nebulizer, Placebo

    Completed
    • COPD
    • Chronic Obstructive Pulmonary Disease
    • SUN-101 50 mcg BID eFlow (CS) nebulizer
    • +2 more
    • Andalusia, Alabama
    • +44 more
    Feb 13, 2018

    COPD Trial in United States (MP-376, Placebo)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Haleyville, Alabama
    • +38 more
    Jan 17, 2018

    COPD Trial in United States (Aclidinium Bromide/Formoterol Fumarate, Formoterol Fumarate)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Aclidinium Bromide/Formoterol Fumarate
    • Formoterol Fumarate
    • Birmingham, Alabama
    • +136 more
    Apr 3, 2017

    COPD Trial in United States (Supplemental oxygen therapy)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Supplemental oxygen therapy
    • Birmingham, Alabama
    • +38 more
    Apr 3, 2017

    COPD Trial in Worldwide (Aclidinium bromide/formoterol Fixed-Dose Combination (FDC), Aclidinium bromide, Formoterol Fumarate)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Aclidinium bromide/formoterol Fixed-Dose Combination (FDC)
    • +3 more
    • Anniston, Alabama
    • +207 more
    Mar 9, 2017

    COPD Trial in Canada, United States (Aclidinium Bromide 200 µg, Aclidinium Bromide 400 µg)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Aclidinium Bromide 200 µg
    • Aclidinium Bromide 400 µg
    • Birmingham, Alabama
    • +112 more
    Mar 9, 2017

    COPD Trial in Worldwide (carmoterol (CHF 4226), salmeterol, )

    Completed
    • Chronic Obstructive Pulmonary Disease
    • carmoterol (CHF 4226)
    • +2 more
    • Jonesboro, Arkansas
    • +49 more
    Apr 7, 2017

    COPD Trial in Australia, New Zealand, United States (GFF MDI, GP MDI, FF MDI)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • GFF MDI
    • +4 more
    • Andalusia, Alabama
    • +139 more
    Feb 7, 2017

    COPD Trial in Worldwide (Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Aclidinium Bromide/Formoterol Fumarate
    • +3 more
    • Anniston, Alabama
    • +221 more
    Feb 2, 2017

    COPD Trial in Australia, New Zealand, United States (PT005 MDI, PT001 MDI, PT003 MDI)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • PT005 MDI
    • +3 more
    • Glendale, Arizona
    • +19 more
    Dec 7, 2016

    COPD Trial in Canada, United States (Aclidinium bromide, Placebo)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Aclidinium bromide
    • Placebo
    • Birmingham, Alabama
    • +111 more
    Nov 30, 2016

    COPD Trial in Canada, United States (Aclidinium bromide)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Aclidinium bromide
    • Birmingham, Alabama
    • +82 more
    Nov 16, 2016